Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Cancers × Crizotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Endometrial Cancer Recurrent 1 Breast Neoplasms 1 Advanced Cancers 1 Adenocarcinoma of Lung 1 ALK or ROS1-positive NSCLC 1

Interventions

ridaforolimus 1 pazopanib 1 Surveys and Questionnaires 1 Pemetrexed 1 Lenalidomide 1 Crizotinib 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01548144 2021-09-13

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Terminated

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡